LGC adds immunosuppressive Proficiency Testing scheme to its portfolio
LGC announced today that it has acquired the world-leading immunosuppressive Proficiency Testing (PT) scheme from ASI, complementing its existing clinical PT portfolio. Currently operated from St George’s – University of London, the scheme includes over 800 participants in 60 countries.
Prof. David Holt will remain closely associated with the scheme, providing expert technical advice and support its development, promotion and delivery. LGC already has in depth experience of the scheme, having produced and distributed test samples used in the scheme for the last 6 years.
Following a short integration, customers will benefit from LGC’s global capability in running PT schemes as well the ability to access the scheme online though LGC’s PT system, ‘PORTAL’.